Translational Development Acquisition Corp.
NASDAQ:TDACShell Companies
-$0.01 today
- Market cap
- $267.99M
- Beta
- 0.01
- P/E (TTM)
- 29.8
- EPS (TTM)
- $0.36
Volume 0.47M
Average 0.10M
TDAC Other Non-current Liabilities
Long-term obligations not reported separately, such as lease or pension liabilities.
Translational Development Acquisition Corp.NASDAQ: TDAC
Other Non-current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Other non-current liabilities broadly unchanged from a year ago
Other non-current liabilities stood at $6.04M at the end of Q1 FY2026, up 0.0% from a year earlier and up 0.0% from the prior quarter.
Context
- Other non-current liabilities amounted to 3.3% of total assets at the end of Q1 FY2026, down 0.1 pp from a year earlier.
- Other non-current liabilities increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether other non-current liabilities keeps rising in the next quarterly balance sheet after a +0.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 6.04M USD
- Year-over-year change
- +0.0%
| Period | Period end | Other Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.04M | +0.0% |
| FY2024 | 2024-12-31 | 6.04M | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
Other Non-current Liabilities vs competitors
How TDAC compares with its peers on the latest reported figures
- TDAC's Mar 2026 other non-current liabilities of $6.04M is the 5th highest of the 7 companies compared; the peer median is $7.99M.
- Its year-over-year change of +0.0% is the 2nd highest of 5, against a peer median of +0.0%.
- Other non-current liabilities amounts to 3.3% of total assets for TDAC, versus a peer median of 4.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $18.9M | -90.7% | — | 9.0% | |
| Mar 2026 | $10.95M | — | +10.3% | 4.6% | |
| Mar 2026 | $9.38M | +17.3% | +15.1% | 5.0% | |
MACIMelar Acquisition Corp. I | Mar 2026 | $6.6M | +0.0% | — | 3.7% |
| Mar 2026 | $6.04M | +0.0% | — | 3.3% | |
NTWONewbury Street II Acquisition Corp | Mar 2026 | $6.04M | +0.0% | — | 3.3% |
| Jun 2025 | $0 | — | — | 0.0% | |
| Peer median (excluding TDAC) | $7.99M | +0.0% | +12.7% | 4.1% | |
Competitors are the stored peer set for TDAC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Translational Development Acquisition Corp.
NASDAQ:TDAC
Intrinsic Alpha fair value
Locked
Current Price
$10.88
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.